Ligand validation:3L68

BU3: (R,R)-2,3-BUTANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3L68_BU3_A_1508	5%	80%	0.305	0.719	0.37	0.48	-	-	1	0	100%	0.8467
3L5L_BU3_A_1508	61%	17%	0.136	0.923	1.25	2.3	1	2	3	1	100%	0.44
3L65_BU3_A_1508	59%	17%	0.146	0.929	1.32	2.28	1	2	4	1	100%	0.49
3N14_BU3_A_2176	30%	14%	0.188	0.852	1.43	2.37	1	2	2	1	100%	1
3L66_BU3_A_1509	15%	12%	0.31	0.876	1.35	2.65	1	2	10	1	100%	1
3L5M_BU3_A_1509	14%	14%	0.275	0.822	1.28	2.57	1	2	4	1	100%	1
4AAN_BU3_A_1347	98%	74%	0.057	0.983	0.37	0.64	-	-	0	0	100%	1
1Z2U_BU3_A_201	97%	79%	0.067	0.984	0.36	0.51	-	-	0	0	100%	1
5AGV_BU3_B_513	96%	75%	0.068	0.977	0.54	0.44	-	-	0	0	100%	1
6R6U_BU3_B_502	92%	89%	0.071	0.962	0.11	0.52	-	-	0	0	100%	1
5LHM_BU3_A_1004	83%	95%	0.075	0.934	0.1	0.31	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.